Babies who are exposed to both bacteria and allergens in the first year of life are less likely to develop asthma and allergies, a study finds.
It's the latest wrinkle in the hygiene hypothesis — the notion that exposure to bacteria trains the infant immune system to attack bad bugs and ignor... Read More
Antibiotic stewardship programs, which promote the appropriate use of antibiotics in hospitals and other healthcare centers, can not only lead to reduction in antibiotic use with no adverse effects but can also lead to significant savings, over $600,000 annually in the case of one New York Ho... Read More
A protein called GRP78 could be a universal therapeutic target for treating human diseases like brain cancer, Ebola, Influenza, Hepatitis and superbug bacteria such as MRSE and MRSA, according to a Virginia Commonwealth University-led pre-clinical study published this month in the Journal of Cel... Read More
The TWiV gang reviews ten fascinating, compelling, and riveting virology stories from 2014.
Dear Vincent, Dickson and Daniel,
I like your idea of a TWIP coffee mug prize (or maybe a mug discount).
In this second case study you presented, the present symptoms are pretty vague, but his history is interesting. Also since with ... Read More
A flu vaccine that works against all flu viruses and provides protection for at least two decades is getting closer to reality, according to scientists at Mount Sinai Health System.
The organization’s vaccine would offer better and broader and longer-lasting protection against seasonal influe... Read More
A North Dakota company that discovered an antibody technology while trying to cure flocks of dying geese is using its research for a more warm and fuzzy purpose: saving puppies.
Early tests performed on about 50 puppies in seven U.S. states for Grand Forks-based Avianax have resulted in a 90 ... Read More
Researchers have developed a high-tech method to rid the body of infections — even those caused by unknown pathogens. A device inspired by the spleen can quickly clean blood of everything from Escherichia coli to Ebola, researchers report on September 14 in Nature Medicine.
Blood infections c... Read More
A decades long fight over cleaning up one of the nation's most contaminated riverbeds has posed a difficult question: how to safely remove enough toxic material from New Jersey's Passaic River to fill two MetLife Stadiums.
The federal government is moving forward with long-stalled efforts to ... Read More
The day we knew would come is finally here. The first locally acquired case of the tropical disease chikungunya was reported in the U.S. today.
The mosquito-borne viral disease first debuted in the Western Hemisphere last year and has since sprawled across the Caribbean, with cases in Puerto ... Read More
The late computer scientist Randy Pausch wrote many inspirational things about life and academia during his struggle with pancreatic cancer. As we approach 2015, his words are helpful to me, and perhaps to others. About life, about academia, about helping others...and making our dreams come tr... Read More
The Ebola virus currently poses the greatest threat to the survival of great apes, conservationists have warned, after killing an estimated third of the world's gorillas and chimpanzees since the 1990s.
The unprecedented current Ebola epidemic in West Africa has killed some 8,641 people, acco... Read More
This episode: Bacterial ghosts could make good vaccines for different things!
(9.8 MB, 10.7 minutes)
The TWiV team consults an epidemiologist to forecast the future scope of the Ebola virus epidemic in West Africa.
A paper just published in nature:
reports an effective antibiot... Read More
In the largest longitudinal study of the microbiome to date, researchers from the Broad Institute of MIT and Harvard, Massachusetts General Hospital (MGH), and the DIABIMMUNE Study Group have identified a connection between changes in gut microbiota and the onset of type 1 diabetes (T1D). The st... Read More
A controversy that has been brewing for several years in the world of influenza research may ignite again with the publication last week of a new paper that’s worth a read. I haven’t to date written about the controversy, which centers on what’s called “gain of function” research. In the case of... Read More
Since the worst Ebola outbreak on record ignited last December in West Africa, scientists have been racing to develop drugs and vaccines to combat the virus. Several experimental drugs have been given to patients, and a new study details how scientists think one of those drugs might neutralize t... Read More